BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36807183)

  • 1. [Two Cases of Transfusion-Free Hepatectomy Following Chemotherapy for H3 Grade of Simultaneous Liver Metastases].
    Ogawa T; Kawamoto S; Yamamoto K; Atarashi M; Terashima T; Kurogi N
    Gan To Kagaku Ryoho; 2023 Feb; 50(2):236-238. PubMed ID: 36807183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
    Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
    Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM).
    Hurwitz HI; Tan BR; Reeves JA; Xiong H; Somer B; Lenz HJ; Hochster HS; Scappaticci F; Palma JF; Price R; Lee JJ; Nicholas A; Sommer N; Bendell J
    Oncologist; 2019 Jul; 24(7):921-932. PubMed ID: 30552157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resection of Multiple Metastases after Liver Resection from Colon Cancer-A Case Report].
    Arakawa S; Kato H; Asano Y; Shimura M; Koike D; Ochi T; Kamio K; Kawai T; Yasuoka H; Higashiguchi T; Kunimura Y; Tochii D; Tochii S; Suda T; Horiguchi A
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1879-1881. PubMed ID: 36733030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of long-term survival due to combined modality therapy for liver metastasis of colon cancer].
    Hasegawa H; Hashimoto T; Nakamura T; Kitagawa M; Kudo K; Shoji F; Kabashima A; Teramoto S; Kitamura M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2234-6. PubMed ID: 23268034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.
    Gruenberger T; Bridgewater J; Chau I; García Alfonso P; Rivoire M; Mudan S; Lasserre S; Hermann F; Waterkamp D; Adam R
    Ann Oncol; 2015 Apr; 26(4):702-708. PubMed ID: 25538173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative chemotherapy with modified FOLFOX + panitumumab for the treatment of descending colon cancer with multiple liver metastases - a case study].
    Yagi Y; Yamazaki T; Iwaya A; Manabe S
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):109-12. PubMed ID: 25596691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter phase II trial of mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808).
    Uetake H; Yasuno M; Ishiguro M; Kameoka S; Shimada Y; Takahashi K; Watanabe T; Muro K; Baba H; Yamamoto J; Mizunuma N; Tamagawa H; Mochizuki I; Kinugasa Y; Kikuchi T; Sugihara K
    Ann Surg Oncol; 2015 Mar; 22(3):908-15. PubMed ID: 25465375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of hepatic resection after chemotherapy for metastatic colon cancer of the liver with invasion of the inferior vena cava and hepatic vein].
    Komatsu H; Tomokuni A; Wada H; Kobayashi S; Tomimaru Y; Asaoka T; Hama N; Kawamoto K; Marubashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2059-61. PubMed ID: 25731422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.
    Andreou A; Kopetz S; Maru DM; Chen SS; Zimmitti G; Brouquet A; Shindoh J; Curley SA; Garrett C; Overman MJ; Aloia TA; Vauthey JN
    Ann Surg; 2012 Oct; 256(4):642-50. PubMed ID: 22968062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Complete Pathological Response of Unresectable Synchronous Colorectal Hepatic Metastasis with Icterus after FOLFOX plus Panitumumab Therapy].
    Umemura K; Miura T; Ishido K; Sakamoto Y; Kudo D; Kimura N; Morohashi H; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2199-2201. PubMed ID: 30692330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of multiple liver metastases from colon cancer treated with complete resection via two-stage hepatectomy after regeneration of the liver].
    Sugishita T; Ganno H; Hataji K; Ami K; Nagahama T; Fukuda A; Ando M; Arai K
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):97-9. PubMed ID: 25596688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of long-term survival following chemotherapy after laparoscopic resection of sigmoid colon cancer with multiple liver metastases].
    Ohashi I; Arai I; Tamura C; Hayashi N; Inoue S; Wakasa T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1758-60. PubMed ID: 25731320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of unresectable multiple hepatic metastases from ascending colon cancer successfully treated with panitumumab and FOLFIRI(5-FU/LV/irinotecan)therapy].
    Yoshida R; Matsuura T; Hijikawa K; Yanagida H; Kitade H; Takada H; Kwon AH
    Gan To Kagaku Ryoho; 2012 Oct; 39(10):1575-7. PubMed ID: 23064076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Three cases of multiple colorectal liver metastases responding to hepatic arterial infusion chemotherapy undergoing liver resection].
    Kobayashi K; Ueki K; Ishizuka D; Wakakuwa R
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):389-91. PubMed ID: 15791824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab.
    Aussilhou B; Dokmak S; Faivre S; Paradis V; Vilgrain V; Belghiti J
    Ann Surg Oncol; 2009 Jun; 16(6):1553-9. PubMed ID: 19363584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Long-Term Survival with Metachronous Hepatic and Pulmonary Metastases from Transverse Colon Cancer by Multidisciplinary Treatment].
    Hara T; Okano M; Hata T; Takayama O; Kim Y; Imamoto H; Hasegawa J
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1857-1859. PubMed ID: 38303231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.
    Yasuno M; Uetake H; Ishiguro M; Mizunuma N; Komori T; Miyata G; Shiomi A; Kagimura T; Sugihara K
    Int J Clin Oncol; 2019 May; 24(5):516-525. PubMed ID: 30612267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two Cases of Advanced Colorectal Cancer Achieving Complete Response by FOLFOXIRI plus Bevacizumab-A Case Report].
    Nemoto T; Endo S; Isohata N; Takayanagi D; Nemoto D; Aizawa M; Utano K; Togashi K; Oshibe I; Soeta N; Saito T
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2410-2412. PubMed ID: 32156948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.
    You YN; Shiozaki H; Lee JE; Passot G; Goumard C; Okuno M; Aloia TA; Eng C; Chang G; Vauthey JN; Conrad C
    Ann Surg Oncol; 2017 Sep; 24(9):2595. PubMed ID: 28510798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.